FMP
Franklin Genomic Advancements ETF
HELX
ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
29.46 USD
-0.1891 (-0.642%)
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
ETF
Description
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
CIK
0001655589
ISIN
US35473P5200
CUSIP
35473P520
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Feb 27, 2020
Key Executives
